Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.17153
Abstract: Key Points Question Is the risk of ventricular tachyarrhythmia similar between women and men with an implantable cardioverter-defibrillator for primary prevention? Findings In this cohort study of 4506 patients with an implantable cardioverter-defibrillator, women and… read more here.
Keywords: implantable cardioverter; cardioverter defibrillator; defibrillator; primary prevention ... See more keywords
State‐of‐the‐art consensus on non‐transvenous implantable cardioverter‐defibrillator therapy
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cardiology"
DOI: 10.1002/clc.23432
Abstract: Within the last decade, implantable cardioverter‐defibrillator (ICD) systems with non‐transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of… read more here.
Keywords: consensus; implantable cardioverter; non transvenous; cardioverter defibrillator ... See more keywords
Outcomes of implantable cardioverter‐defibrillator implantation in HIV‐infected patients: A single‐center retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23868
Abstract: HIV‐infected individuals have a known increased risk of sudden cardiac death (SCD) compared to uninfected individuals. Implantable cardioverter‐defibrillators (ICDs) are standard therapy for preventing SCD; however, there is limited data on the outcomes of ICDs… read more here.
Keywords: hiv; outcomes implantable; hiv infected; cardioverter defibrillator ... See more keywords
Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
Sign Up to like & getrecommendations! Published in 2021 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13340
Abstract: Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is a lack of evidence whether patients… read more here.
Keywords: friend foe; wearable cardioverter; cardioverter defibrillator; defibrillator friend ... See more keywords
Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14249
Abstract: This systematic review evaluated the clinical effectiveness and safety of subcutaneous implantable cardioverter‐defibrillator (S‐ICD) in patients at an increased risk of sudden cardiac death and with an ICD indication for primary or secondary prevention. A… read more here.
Keywords: systematic review; observational studies; subcutaneous implantable; effectiveness safety ... See more keywords
Simultaneous leadless pacemaker and subcutaneous implantable cardioverter‐defibrillator implantation—When vascular options have run out
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12140
Abstract: An end‐stage renal failure patient who was planned for a left brachioaxillary arteriovenous graft required an implantable cardioverter‐defibrillator for secondary prevention of ventricular tachycardia and a pacemaker for complete heart block but was found to… read more here.
Keywords: pacemaker; implantable cardioverter; cardioverter defibrillator; implantation ... See more keywords
Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12234
Abstract: Clinical features and complications of subcutaneous implantable cardioverter‐defibrillator (S‐ICD) implantation for Brugada syndrome have not been well studied. read more here.
Keywords: subcutaneous implantable; brugada syndrome; implantable cardioverter; complications subcutaneous ... See more keywords
RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12551
Abstract: An implantable cardioverter defibrillator (ICD) is the most reliable therapeutic device for preventing sudden cardiac death in patients with sustained ventricular tachycardia (VT). Regarding its effectiveness, targeted VT is defined based on the tachyarrhythmia cycle… read more here.
Keywords: interval variability; ventricular tachycardia; variability; therapy ... See more keywords
Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Heart and Vessels"
DOI: 10.1007/s00380-017-0994-3
Abstract: AbstractScreening tests conducted at rest may be inadequate for the prediction of the T-wave oversensing (TWOS) in subcutaneous implantable cardioverter defibrillator (S-ICD) candidates with Brugada syndrome (BrS) because of the dynamic nature of electrocardiogram (ECG)… read more here.
Keywords: prediction wave; subcutaneous implantable; wave oversensing; implantable cardioverter ... See more keywords
Determinants of inappropriate implantable cardioverter-defibrillator shocks: the German Device Registry perspective
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Interventional Cardiac Electrophysiology"
DOI: 10.1007/s10840-019-00600-4
Abstract: In the present study, we have focused upon rates and clinical determinants of inappropriate shock (IS) after implantable cardioverter-defibrillator (ICD). Data were collected prospectively in the German Device II Registry. A total of 783 patients… read more here.
Keywords: determinants inappropriate; device registry; german device; implantable cardioverter ... See more keywords
Assessment of Implantable Cardioverter-Defibrillator Used in Heart Failure with Reduced Ejection Fraction as Primary Prevention in an Underserved Population
Sign Up to like & getrecommendations! Published in 2018 at "Journal of General Internal Medicine"
DOI: 10.1007/s11606-018-4544-1
Abstract: Implantable cardioverter-defibrillator (ICD) implantation has been one of the milestones in the treatment of heart failure providing a significant survival benefit. Current guidelines recommend that patients who have a sustained low left ventricular ejection fraction… read more here.
Keywords: implantable cardioverter; ejection fraction; cardioverter defibrillator; heart failure ... See more keywords